The Ibero-American transcatheter aortic valve implantation registry with the CoreValve prosthesis. Early and long-term results

Muñoz-García, Antonio J.; Valle, Raquel del; Trillo-Nouche, Ramiro; Elı́zaga, Jaime; Gimeno, Federico; Hernández‐Antolín, Rosana; Teles, Rui Campante; Ribeiro, Vasco De Gama; Molina, Eduardo; Cequier, Ángel; Urbano-Carrillo, Cristóbal A.; Cruz-González, Ignacio; Payaslian, Miguel; Patrício, Lino; Sztejfman, Matías; Íñiguez, Andrés; Rodríguez, Víctor Manuel Velasco; Scuteri, Antonio; Caorsi, Carlos E.; López-Otero, Diego; Avanzas, Pablo; Alonso‐Briales, Juan H.; Hernández-García, José M.; Morı́s, César

doi:10.1016/j.ijcard.2013.09.006

Cited by 42 publications

(25 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After applying inclusion and exclusion criteria to the full text articles, 72 articles were removed, while the full text screening and 4 articles were removed during data extraction. Finally, 15 publications were selected for the present study . The study selection process is presented in Figure .…”

Section: Resultsmentioning

confidence: 99%

Impact of Coronary Artery Disease on 30‐Day and 1‐Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta‐Analysis

Sankaramangalam

Banerjee

Kandregula

et al. 2017

JAHA

109

View full text Add to dashboard Cite

BackgroundThe impact of coronary artery disease (CAD) on outcomes after transcatheter aortic valve replacement (TAVR) is understudied. Literature on the prognostic role of CAD in the survival of patients undergoing TAVR shows conflicting results. This meta‐analysis aims to investigate how CAD impacts patient survival following TAVR.Methods and ResultsWe completed a comprehensive literature search of Embase, MEDLINE, and the Cochrane Library, and included studies reporting outcome of TAVR based on CAD status of patients for the analysis. From the initial 1631 citations, 15 studies reporting on 8013 patients were analyzed using a random‐effects model. Of the 8013 patients undergoing TAVR, with a median age of 81.3 years (79–85.1 years), 46.6% (40–55.7) were men and 3899 (48.7%) had CAD (ranging from 30.8% to 78.2% in various studies). Overall, 3121 SAPIEN/SAPIEN XT/SAPIEN 3 (39.6%) and 4763 CoreValve (60.4%) prostheses were implanted, with transfemoral access being the most frequently used approach for the implantation (76.1%). Our analysis showed no significant difference between patients with and without CAD for all‐cause mortality at 30 days post TAVR, with a cumulative odds ratio of 1.07 (95% confidence interval, 0.82–1.40; P=0.62). However, there was a significant increase in all‐cause mortality at 1 year in the CAD group compared with patients without CAD, with a cumulative odds ratio of 1.21 (95% confidence interval, 1.07–1.36; P=0.002).ConclusionsEven though coexisting CAD does not impact 30‐day mortality, it does have an impact on 1‐year mortality in patients undergoing TAVR. Our results highlight a need to revisit the revascularization strategies for concomitant CAD in patients with TAVR.

show abstract

Section: Resultsmentioning

confidence: 99%

Impact of Coronary Artery Disease on 30‐Day and 1‐Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta‐Analysis

Sankaramangalam

Banerjee

Kandregula

et al. 2017

JAHA

109

View full text Add to dashboard Cite

show abstract

“…[4][5][6][7][8] In some of these studies, COPD was defined by clinical symptoms (progressive dyspnea, cough, wheezing, or sputum production) and medication (long-term use of bronchodilators or steroids). 4,6,7 However, the accurate clinical diagnosis of COPD may be difficult in patients with symptomatic severe AS. In addition, our study illustrates that not all patients with COPD received drug therapy-in particular patients with mild COPD (Table IV).…”

Section: Copd and Outcomementioning

confidence: 99%

“…2,3 Recently, some studies reported about the prognostic impact of chronic obstructive pulmonary disease (COPD) in patients who underwent TAVI. [4][5][6][7][8] However, there is no study that has examined patients by means of spirometry and body plethysmography before TAVI. In particular, it is unclear whether different degrees of severity of COPD have a prognostic significance.…”

mentioning

confidence: 99%

Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: Insights from spirometry and body plethysmography

Gotzmann

Knoop

Ewers

et al. 2015

American Heart Journal

View full text Add to dashboard Cite

“…pacemaker implantation after TAVI with this device on survival or stroke. 17- 19 One patient did not receive the MDT-2111 TAV because of a low take-off of the left coronary artery. This was discovered during preoperative CT assessment and aortography during pre-TAVI BAV, which showed the possibility of coronary obstruction by the native valve.…”

Section: Secondary Endpointsmentioning

confidence: 99%

First Clinical Trial of a Self-Expandable Transcatheter Heart Valve in Japan in Patients With Symptomatic Severe Aortic Stenosis

Sawa

Saïto

Kobayashi

et al. 2014

Circ J

View full text Add to dashboard Cite

The Ibero-American transcatheter aortic valve implantation registry with the CoreValve prosthesis. Early and long-term results

Cited by 42 publications

References 32 publications

Impact of Coronary Artery Disease on 30‐Day and 1‐Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta‐Analysis

Impact of Coronary Artery Disease on 30‐Day and 1‐Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta‐Analysis

Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: Insights from spirometry and body plethysmography

First Clinical Trial of a Self-Expandable Transcatheter Heart Valve in Japan in Patients With Symptomatic Severe Aortic Stenosis

Contact Info

Product

Resources

About